Quick answer
How is BPC-157 reconstituted and stored in the laboratory? Keep the sealed lyophilized vial refrigerated at 2–8 °C, or at −20 °C for long-term holding, away from heat, moisture and light. Let a cold vial reach room temperature before opening, run a water-based diluent down the glass wall, and swirl rather than shake until the liquid is clear. Use bacteriostatic water when one vial will be entered repeatedly and sterile water when the stock is divided and frozen straight away. Refrigerate working stock, freeze single-use aliquots for longer studies, thaw each aliquot once, and write the lot, diluent, concentration and date on everything.
BPC-157 is one of the more forgiving peptides to handle, and that is exactly why it gets handled carelessly. Its fifteen residues contain no sulfur and no aromatic side chain, so the oxidation and light problems that dominate other handling guides barely apply. What does apply is aspartic acid chemistry, moisture uptake by the dry cake, and ordinary microbiological hygiene. This guide walks through the lyophilized vial, the reasoning behind diluent choice, storage tiers, freeze–thaw behaviour, visual checks and record-keeping. The material is supplied for laboratory research use only and is not for human or animal consumption.
What arrives: the lyophilized BPC-157 vial
The BPC-157 research vial is listed as a 10 mg lyophilized powder at a purity specification of ≥98% by HPLC, in a sealed clear glass vial. Freeze-drying removes water by sublimation from a frozen solution, leaving a porous solid; the process is described in what is lyophilization. A peptide filled without a bulking agent often does not form a tall, uniform plug. A thin white disc at the bottom, a fluffy film on the wall, or a few loose flakes are all normal presentations of the same mass. Appearance says little about quantity, and a cake that broke loose in transit is not degraded.
| Property (from the product listing) | Value | Handling consequence |
|---|---|---|
| Vial size | 10 mg | The starting figure for every concentration calculation |
| Purity specification | ≥98% by HPLC | Compare with the figure on the certificate for the lot, where published |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Identity check against the certificate |
| Length | 15 amino acids | Short and unstructured; dissolves quickly in water |
| Supplied form | Lyophilized powder | Low-moisture solid; most stable state of the material |
| Container | Sealed clear glass vial | Clear glass gives no light protection, so keep it boxed |
| Storage line | Refrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and light | Defines the two dry-storage tiers used below |
Before the seal is broken, match the lot number on the label to the document in the COA library. The certificate, where published, reports HPLC purity and identity for that lot; how to read a COA explains each field. Background on the compound itself sits in the BPC-157 research overview.
BPC-157 chemistry that shapes handling decisions
Reading the sequence residue by residue tells a laboratory which precautions matter and which are habit carried over from other peptides.
- No methionine, cysteine or tryptophan. The three side chains most easily oxidized in peptides are absent. There is no methionine sulfoxide to form, no disulfide to scramble, and no indole ring to photo-oxidize. Oxygen exclusion, which is central for sulfur-containing peptides, is a minor concern here.
- No aromatic residue at all. With no tryptophan, tyrosine or phenylalanine, BPC-157 has essentially no absorbance at 280 nm. Any attempt to estimate concentration from an A280 reading will fail; analytical work relies on the peptide-bond region at low UV wavelengths, as described in understanding HPLC purity.
- Two adjacent aspartic acids. The Asp-Asp-Ala stretch is the main chemical liability. Aspartyl residues can cyclize to a succinimide and reopen as a mixture of normal and iso-aspartyl forms, and Asp-X bonds are prone to hydrolysis under acidic conditions. The classic fast case is Asp-Gly, which this sequence does not contain; an alanine or a second aspartate as the following residue reacts more slowly. The practical lesson is to avoid storing solutions at low pH or warm temperature.
- Four prolines. The Pro-Pro-Pro run and the fourth proline make the backbone rigid and resistant to forming the β-sheet aggregates seen with longer hydrophobic peptides. Gelling or fibril formation is not an expected failure mode.
- Net acidic character. One glutamate, two aspartates and the C-terminal carboxyl outweigh the single lysine and the N-terminal amine, so the peptide carries a net negative charge near neutral pH. It dissolves readily in plain water, and it is less inclined to stick to negatively charged glass than strongly cationic peptides are.
- Counter-ion. Synthetic peptides are isolated as salts, commonly acetate or trifluoroacetate, and the salt form affects net peptide content and the pH of an unbuffered solution. The product listing does not state the counter-ion, so take it from the certificate rather than assuming.
Solvent choice: the reasoning, not a recipe
Because BPC-157 is freely water-soluble, the diluent decision is not about getting the peptide into solution. It is about what the solution has to survive afterwards: repeated stopper punctures, days in a refrigerator, a freeze, or contact with cultured cells.
| Diluent | Suits | Strength | Limitation |
|---|---|---|---|
| Bacteriostatic water (water with 0.9% benzyl alcohol) | A stock vial entered several times over a working period | The preservative suppresses growth of organisms introduced at each puncture | Benzyl alcohol is biologically active in some cell assays; run a matched vehicle control |
| Sterile water | Stock that is aliquoted and frozen at once, or consumed the same day | No additive to account for in cell culture or analytical work | No preservative; unsuitable as a multi-entry refrigerated vial |
| Buffered saline | Final working dilutions made at the bench | Controlled pH and ionic strength for the assay | Phosphate buffers can shift pH as they freeze; a poor choice for frozen stock |
| Dilute acid or organic co-solvent | Not needed for this peptide | Rescues peptides that resist water | Acid encourages Asp-X hydrolysis; no reason to accept that risk here |
The fourth row is the compound-specific point. A drop of dilute acetic acid is a standard rescue for basic peptides, but BPC-157 is acidic and aspartate-rich, so acid offers nothing and attacks the weakest bonds in the chain. The general logic of preserved versus unpreserved water is set out in bacteriostatic water explained. Volume arithmetic is deliberately left out of this page: enter the vial mass and intended volume into the reconstitution calculator and record the result.
Reconstitution technique at the bench
The full generic procedure is in how to reconstitute a lyophilized peptide. The points below are the ones that matter most for this vial.
- Equilibrate before opening. A vial taken from cold storage and pierced immediately draws humid room air onto a cold, hygroscopic cake. Leave it sealed on the bench until it no longer feels cold.
- Settle the powder. Tap the vial base on the bench so loose flakes fall away from the stopper, where they would otherwise escape the liquid.
- Disinfect and let dry. Swab both stoppers with alcohol and wait for it to evaporate so no solvent is carried in on the needle or tip.
- Add diluent down the wall. Direct the stream against the glass, not onto the cake, to avoid foaming and to wet the solid evenly.
- Swirl, do not shake. BPC-157 goes into solution within moments. Vigorous shaking only creates foam and leaves peptide stranded in bubbles on the wall.
- Inspect, then label. Confirm clarity against a dark and a light background before the vial goes anywhere near a refrigerator.
Storage tiers for BPC-157
The product listing gives one storage line: refrigerate at 2–8 °C, use −20 °C for long-term storage, and protect from heat, moisture and light. Everything else in the table is general laboratory practice for short peptides in solution, not a validated shelf life for a particular lot.
| State | Tier | Use it for | Notes |
|---|---|---|---|
| Lyophilized, sealed | −20 °C | Long-term holding | Boxed, dry, in a manual-defrost freezer where possible |
| Lyophilized, sealed | 2–8 °C | Vials that will be opened in the near term | Keep away from the door and the cooling plate |
| Lyophilized, sealed | Ambient | Transit only | Move to cold storage on receipt; see the room-temperature note below |
| Solution in bacteriostatic water | 2–8 °C | Multi-entry working stock | Preserved multi-use containers are conventionally discarded after about four weeks |
| Solution in sterile water | 2–8 °C | Same-day or next-day use | No preservative; aliquot and freeze instead of keeping it |
| Single-use aliquots | −20 °C or colder | Studies that run for months | One thaw per tube |
| Diluted in buffer or medium | Bench | The experiment in hand | Prepare fresh and discard the remainder |
Broader context is in storing research peptides and how long reconstituted peptides last. Questions about a vial left out on a bench or delayed in transit are handled separately in BPC-157 room-temperature stability.
Freeze–thaw cycles and aliquoting
Freezing a peptide solution is a stress, not a pause button. As ice crystals grow, the peptide, its counter-ions and any buffer salts are squeezed into a shrinking liquid fraction where concentration climbs and pH can drift. For an aspartate-rich sequence, a transient acidic, concentrated phase is precisely the environment that favours isomerization and hydrolysis. One pass through that phase is routinely tolerated by short peptides; repeating it with the same tube adds exposure for no benefit.
Aliquoting removes the problem at the source. Immediately after reconstitution, divide the stock into volumes sized for a single session, freeze them together, and thaw only what the day requires. Thaw in a refrigerator or on ice, mix by gentle inversion because solutes stratify on freezing, and discard what is left. Frost-free freezers warm their contents during each defrost cycle, so a manual-defrost unit or an insulated box inside the freezer gives a steadier temperature.
Light, moisture and surface adsorption
Moisture is the dominant risk to the dry cake. Residual water content governs solid-state reaction rates, and aspartyl isomerization proceeds faster in a cake that has taken up water. Keep the crimp intact, never store a vial with a punctured stopper as if it were still sealed, and equilibrate cold vials before opening.
Light matters less for BPC-157 than for peptides with tryptophan or tyrosine, because there is no chromophore that absorbs strongly in the near UV. The storage line still calls for protection from light, and a closed box costs nothing, so the instruction is worth following for consistency across a peptide inventory.
Adsorption becomes significant when solutions are dilute. Any peptide can be lost to container walls at low concentration, and recovery differs between glass and plastic types. Keep the stock concentrated, make dilute working solutions immediately before use, and choose low-binding polypropylene for aliquots.
Visual quality checks before each use
- Dry vial: white to off-white solid; crimp and stopper intact; no liquid droplets, no glassy collapsed residue, no discoloration.
- Fresh solution: clear and colorless within a minute or two of gentle swirling. Small bubbles should rise and clear.
- Stored solution: re-examine against black and white backgrounds every time. Haze, floating fibres, a film on the glass or any tint is a reason to discard, not to filter and continue.
- After thawing: schlieren lines that vanish on mixing are normal; particles that persist are not.
Because BPC-157 dissolves so easily, turbidity is more often a sign of contamination, a wrong diluent or a compromised vial than of slow dissolution. Troubleshooting steps are collected in cloudy peptide vial after reconstitution. A visual check cannot detect iso-aspartyl forms or hydrolysis fragments; only chromatography can, which is why BPC-157 purity testing is worth reading alongside this guide.
Records and labelling
An unlabelled vial has an unknown concentration and an unknown age, which makes any result obtained with it unrepeatable. Capture the following at the time of reconstitution, not from memory afterwards:
- Compound name, vial size and lot number, with the certificate filed or linked
- Date received and the storage tier used until opening
- Diluent identity, its own lot and expiry, and the volume added
- Calculated stock concentration and how it was derived
- Date and initials at reconstitution; date of first puncture for multi-entry vials
- Number, volume and freezer location of aliquots
- Each thaw, each visual inspection result, and the date of disposal
On the container itself, a solvent-resistant label with compound, concentration, date and lot is the minimum. Laboratories comparing sources or reordering can find documentation criteria in where to buy BPC-157.
What not to do
- Do not shake or vortex the vial; foaming strands peptide on the glass.
- Do not reach for acetic acid or another acid to "help" dissolution of an already soluble, acid-sensitive sequence.
- Do not keep an unpreserved sterile-water solution in a refrigerator for weeks.
- Do not refreeze a thawed aliquot or freeze a multi-entry vial between uses.
- Do not estimate concentration by A280; the peptide has no aromatic residue.
- Do not store stock in culture medium or phosphate buffer.
- Do not combine different peptides in one vial unless the study is designed around it; mixed stocks are covered in BPC-157 and TB-500 blend reconstitution.
- Do not open a cold vial, and do not leave vials loose under bench lighting.
What the published stability data do and do not show
Honesty about the evidence is part of good handling. The research group that has published most on this pentadecapeptide repeatedly describes it as stable, including reports of persistence in gastric juice, and those statements appear in several of its reviews. They are descriptions drawn from the biological literature. A peer-reviewed, stability-indicating study that tracks a reconstituted research vial in bacteriostatic water by HPLC over weeks, at defined temperatures, does not appear to be available in the open literature.
It follows that no specific percentage of intact peptide after a given number of days can be quoted responsibly, and none is quoted here. The storage tiers above rest on three things: the storage line on the product listing, the well-characterized chemistry of aspartyl residues and lyophilized solids, and general conventions for preserved multi-entry containers. A laboratory whose conclusions depend on exact potency over a long protocol should verify its own stock chromatographically at the start and end of the study, or reconstitute fresh material partway through.
Summary
BPC-157 lacks the oxidation-prone and light-sensitive residues that complicate many peptides, dissolves at once in water, and is not prone to aggregation. Its handling risks are quieter: moisture in the dry cake, acidic or warm solution conditions acting on the Asp-Asp-Ala segment, microbial growth in unpreserved liquid, and losses from dilute solutions. Store the sealed vial cold and dark, choose the diluent by how the stock will be used, aliquot instead of refreezing, look at the solution every time, and keep records complete enough that another researcher could reproduce the preparation.
Frequently asked questions
What does lyophilized BPC-157 look like in the vial?
A white to off-white solid that may appear as a thin disc, a film on the glass or loose flakes. Peptides filled without a bulking agent rarely form a tall plug, and a cake that has broken up in transit contains the same mass as an intact one.
Is bacteriostatic water or sterile water better for BPC-157 in the lab?
Neither is better in general. Bacteriostatic water suits a stock vial that will be entered several times, because the benzyl alcohol preservative limits microbial growth. Sterile water suits stock that is aliquoted and frozen immediately or used in assays where benzyl alcohol would interfere.
At what temperature should the lyophilized vial be stored?
The product listing states refrigeration at 2–8 °C, with −20 °C for long-term storage, and protection from heat, moisture and light.
How long is reconstituted BPC-157 stable?
No peer-reviewed, stability-indicating study of a reconstituted research vial appears to be published, so an exact figure cannot be given. Laboratories generally follow the convention of discarding preserved multi-entry solutions after about four weeks under refrigeration and freezing single-use aliquots for longer work.
Does BPC-157 oxidize like methionine-containing peptides?
The sequence contains no methionine, cysteine or tryptophan, so the common oxidation routes do not apply. Its main chemical liability is the pair of aspartic acid residues, which can isomerize or hydrolyze, particularly under acidic or warm conditions.
Can BPC-157 concentration be measured by absorbance at 280 nm?
No. The peptide has no tryptophan, tyrosine or phenylalanine and therefore has essentially no absorbance at 280 nm. Concentration is normally taken from the vial mass and added volume, corrected with certificate data when precision is required.
How many freeze-thaw cycles are acceptable?
Plan for one. Divide the stock into single-session aliquots after reconstitution so that no tube is thawed twice, and thaw on ice or in a refrigerator.
What should a correctly reconstituted solution look like?
Clear and colorless with no visible particles. Persistent haze, fibres, a film on the glass or any tint means the solution should be discarded.
Should acetic acid be used to help BPC-157 dissolve?
No. The peptide is acidic and dissolves readily in plain water. Acid adds nothing and promotes hydrolysis at aspartic acid residues.
Where is the calculation for stock concentration?
This guide intentionally gives no volumes. Enter the vial mass and the planned diluent volume into the reconstitution calculator on the site and record the result in the lab notebook.
What should be written on the vial after reconstitution?
Compound name, lot number, diluent, calculated concentration, date of reconstitution and initials. The notebook entry should add diluent lot, aliquot count and location, and every thaw and inspection.
References
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632. doi:10.2174/138161211796196954
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. doi:10.1152/japplphysiol.00945.2010
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. doi:10.1016/S0021-9258(19)75855-4
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
